Download PDF
Thromb Haemost 1993; 70(01): 080-086
DOI: 10.1055/s-0038-1646165
State-of-the-Art Lecture
Plateley Receptors
Schattauer GmbH Stuttgart

On the Existence of Platelet Receptors for Factor V(a) and Factor VIII(a)

Michael E Nesheim
Departments of Biochemistry and Medicine, Queen's University, Kingston, Ontario, CANADA
,
Emilia Furmaniak-Kazmierczak
Departments of Biochemistry and Medicine, Queen's University, Kingston, Ontario, CANADA
,
Christine Henin
Departments of Biochemistry and Medicine, Queen's University, Kingston, Ontario, CANADA
,
Graham Côté
Departments of Biochemistry and Medicine, Queen's University, Kingston, Ontario, CANADA
› Author Affiliations
Further Information

Publication History

Publication Date:
03 July 2018 (online)

  PDF Download  Permissions and Reprints
 

  • References

  • 1 Tracy PB. Regulation of thrombin generation at cell surfaces. Semin Thromb Hemostas 1988; 14: 227-233
    Article in Thieme ConnectPubMedGoogle Scholar
  • 2 Mann KG, Nesheim ME, Church WR, Haley P, Krishnaswamy S. Surface dependent reactions of the vitamin K dependent enzyme complexes. Blood 1990; 76: 1-16
    PubMedGoogle Scholar
  • 3 Rawala-Sheikh R, Ahmad SS, Ashby B, Walsh PN. Kinetics of coagulation factor X activation by platelet bound factor IXa. Biochemistry 1990; 29: 2606-2611
    CrossrefPubMedGoogle Scholar
  • 4 van Rijn J, Rosing J, van Dieijen G. Activity of human blood platelets in prothrombin and in factor X activation induced by ionophore A23187. Eur J Biochem 1983; 133: 1-10
    CrossrefPubMedGoogle Scholar
  • 5 Tracy PB, Eide LL, Mann KG. Human prothrombinase complex assembly and function on isolated peripheral blood cell populations. J Biol Chem 1985; 260: 2119-2124
    PubMedGoogle Scholar
  • 6 Miletich JP, Jackson CM, Majerus PW. Properties of the factor Xa binding site on human platelets. J Biol Chem 1978; 253: 6908-6916
    PubMedGoogle Scholar
  • 7 Rosing J, van Rijn JLML, Bevers EM, van Dieijen G, Comfurius P, Zwaal RFA. The role of activated human platelets in prothrombin and factor X activation. Blood 1985; 65: 319-332
    PubMedGoogle Scholar
  • 8 Tracy PB, Nesheim ME, Mann KG. Coordinate binding of factor Va and factor Xa to the unstimulated platelet. J Biol Chem 1981; 256: 743-751
    PubMedGoogle Scholar
  • 9 Ahmad SS, Rawala-Sheikh R, Monroe DM, Roberts HR, Walsh PN. Comparative platelet binding and kinetic studies with normal and variant factor IXa molecules. J Biol Chem 1990; 265: 20907-20911
    PubMedGoogle Scholar
  • 10 Nesheim ME, Taswell JB, Mann KG. The contribution of bovine factor V and factor Va to the activity of prothrombinase. J Biol Chem 1979; 254: 10952-10962
    PubMedGoogle Scholar
  • 11 Rosing J, Tans G, Govers-Riemslag JWP, Zwaal RFA, Hemker HC. The role of phospholipids and factor Va in the prothrombinase complex. J Biol Chem 1980; 255: 274-283
    PubMedGoogle Scholar
  • 12 van Dieijen G, Tans G, Rosing J, Hemker HC. The role of phospholipid and factor Villa in the activation of bovine factor X. J Biol Chem 1981; 256: 3433-3442
    PubMedGoogle Scholar
  • 13 Sims PJ, Wiedmer T, Esmon CT, Weiss HJ, Shattil SJ. Assembly of the platelet prothrombinase complex is linked to vesiculation of the platelet plasma membrane. Studies in Scott syndrome: an isolated defect in platelet procoagulant activity. J Biol Chem 1989; 264: 17049-17057
    PubMedGoogle Scholar
  • 14 Gilbert GE, Sims PJ, Wiedmer T, Furie B, Furie BC, Shattil SJ. Platelet derived microparticles express high affinity receptors for factor VIII. J Biol Chem 1991; 266: 17261-17268
    PubMedGoogle Scholar
  • 15 Zwaal RFA, Comfurius P, Bevers EM. Platelet procoagulant activity and microvesicle formation. Its putative role in hemostasis and thrombosis. Biochim Biophys Acta 1992; 1180: 1-8
    CrossrefPubMedGoogle Scholar
  • 16 Sims PJ, Faioni EM, Wiedmer T, Shattil SJ. Complement proteins C5b-9 cause release of membrane vesicles from the platelet surface that are enriched in the membrane receptor for coagulation factor Va and express prothrombinase activity. J Biol Chem 1988; 263: 18205-18212
    PubMedGoogle Scholar
  • 17 Krishnaswamy S, Mann KG. The binding of factor Va to phospholipid vesicles. J Biol Chem 1988; 263: 5714-5723
    PubMedGoogle Scholar
  • 18 Nesheim ME, Pittman DD, Wang JH, Slonosky D, Giles AR, Kaufman RJ. The binding of 35S labeled recombinant factor VIII to activated and unactivated human platelets. J Biol Chem 1988; 263: 16467-16470
    PubMedGoogle Scholar
  • 19 Gilbert GE, Furie BC, Furie B. Binding of human factor VIII to phospholipid vesicles. J Biol Chem 1990; 265: 815-822
    PubMedGoogle Scholar
  • 20 Gilbert GE, Drinkwater D, Barter S, Clouse SB. Specificity of phosphatidylserine containing membrane binding sites for factor VIII. Studies with model membranes supported by glass microspheres (lipospheres). J Biol Chem 1992; 267: 15861-15868
    PubMedGoogle Scholar
  • 21 Tracy PB, Peterson JM, Nesheim ME, McDuffie FC, Mann KG. Interaction of coagulation factor V and factor Va with platelets. J Biol Chem 1979; 254: 10354-10361
    PubMedGoogle Scholar
  • 22 Kane WH, Majerus PW. The interaction of human coagulation factor Va with platelets. J Biol Chem 1982; 257: 3963-3969
    PubMedGoogle Scholar
  • 23 Miletich JP, Kane WH, Hofmann SL, Stanford N, Majerus PW. Deficiency of factor Xa-factor Va binding sites on the platelets of a patient with a bleeding disorder. Blood 1979; 54: 1015-1022
    PubMedGoogle Scholar
  • 24 Tracy PB, Nesheim ME, Mann KG. Platelet factor Xa receptor. Methods Enzymol 1992; 215: 329-360
    PubMedGoogle Scholar
  • 25 Danielsson A, Raub E, Lindahl U, Bjork I. Role of ternary complexes, in which heparin binds both antithrombin and proteinase, in the acceleration of the reactions between antithrombin and thrombin or factor Xa. J Biol Chem 1986; 261: 15467-15473
    PubMedGoogle Scholar
  • 26 Bjork I, Lindahl U. Mechanism of the anticoagulant action of heparin. Mol Cellul Biochem 1982; 48: 161-182
    PubMedGoogle Scholar
  • 27 Olson ST, Bjork I, Sheffer R, Craig PA, Shore JD, Choay J. Role of the antithrombin binding pentasaccharide in heparin acceleration of antithrombin proteinase reactions. Resolution of the antithrombin conformational change contribution to heparin rate enhancement. J Biol Chem 1992; 267: 12528-12538
    CrossrefPubMedGoogle Scholar
  • 28 Olson ST, Shore JD. Demonstration of a two step reaction mechanism for inhibition of alpha thrombin by antithrombin III and identification of the step affected by heparin. J Biol Chem 1982; 257: 14891-14895
    PubMedGoogle Scholar
  • 29 Nesheim ME. A simple rate law that describes the kinetics of the heparin catalyzed reaction between antithrombin III and thrombin. J Biol Chem 1983; 258: 14708-14717
    PubMedGoogle Scholar
  • 30 Nesheim ME, Blackburn MN, Lawler CM, Mann KG. Dependence of antithrombin III and thrombin binding stoichiometries and catalytic activity on the molecular weight of affinity purified heparin. J Biol Chem 1986; 261: 3214-3221
    PubMedGoogle Scholar
  • 31 Olson ST, Halvorson HR, Bjork I. Quantitative characterization of the thrombin heparin interaction. Discrimination between specific and nonspecific binding models. J Biol Chem 1991; 266: 6342-6352
    PubMedGoogle Scholar
  • 32 Malhotra OP, Nesheim ME, Mann KG. The kinetics of activation of normal and gamma carboxyglutamic acid deficient prothrombins. J Biol Chem 1985; 260: 279-287
    PubMedGoogle Scholar
  • 33 Nesheim ME, Tracy RP, Mann KG. “Clotspeed”, a mathematical simulation of the functional properties of prothrombinase. J Biol Chem 1984; 259: 1447-1453
    CrossrefPubMedGoogle Scholar